Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Anderson

Showing results (11-20 of 395) with videos related to

Pageof 40
Sort By:
Current Opinion in Cardiology|June 9, 2007
Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosisJohn Carlquist, Jeffrey L Anderson
Journal of the American College of Cardiology|June 12, 2003
Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet?Jeffrey L Anderson, John F Carlquist
JACC. Cardiovascular Interventions|April 20, 2010
Bypass surgery after non-ST-segment elevation myocardial infarction better early than late?Jeffrey L Anderson, John R Doty
Circulation|May 12, 2010
Birthing the genetics of peripartum cardiomyopathyJeffrey L Anderson, Benjamin D Horne
Journal of the American College of Cardiology|July 31, 2010
The 9p21 locus and coronary heart disease: initiator, promoter, or precipitator?Jeffrey L Anderson, Benjamin D Horne
The American Journal of Medicine|December 25, 2003
Should C-reactive protein be measured routinely during acute myocardial infarction?James S Zebrack, Jeffrey L Anderson
Journal of Cardiovascular Electrophysiology|January 28, 2005
Nonlinear heart rate variability: a better ECG predictor of cardiovascular risk?Jeffrey L Anderson, Benjamin D Horne
Texas Heart Institute Journal|April 6, 2004
Antibiotic trials for coronary heart diseaseJeffrey L Anderson, Joseph B Muhlestein
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 30, 2013
Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillatorsT Jared Bunch, Jeffrey L Anderson
Journal of the American College of Cardiology|October 21, 2015
Haptoglobin 2-2 Genotyping for Refining Standard Cardiovascular Risk Assessment: A Promising Proposition in Need of ValidationBenjamin D Horne, Jeffrey L Anderson
Pageof 40

Showing results (11-20 of 395) with videos related to

Sort By:
Pageof 40
Current Opinion in Cardiology|June 9, 2007
Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosisJohn Carlquist, Jeffrey L Anderson
Journal of the American College of Cardiology|June 12, 2003
Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet?Jeffrey L Anderson, John F Carlquist
JACC. Cardiovascular Interventions|April 20, 2010
Bypass surgery after non-ST-segment elevation myocardial infarction better early than late?Jeffrey L Anderson, John R Doty
Circulation|May 12, 2010
Birthing the genetics of peripartum cardiomyopathyJeffrey L Anderson, Benjamin D Horne
Journal of the American College of Cardiology|July 31, 2010
The 9p21 locus and coronary heart disease: initiator, promoter, or precipitator?Jeffrey L Anderson, Benjamin D Horne
The American Journal of Medicine|December 25, 2003
Should C-reactive protein be measured routinely during acute myocardial infarction?James S Zebrack, Jeffrey L Anderson
Journal of Cardiovascular Electrophysiology|January 28, 2005
Nonlinear heart rate variability: a better ECG predictor of cardiovascular risk?Jeffrey L Anderson, Benjamin D Horne
Texas Heart Institute Journal|April 6, 2004
Antibiotic trials for coronary heart diseaseJeffrey L Anderson, Joseph B Muhlestein
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 30, 2013
Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillatorsT Jared Bunch, Jeffrey L Anderson
Journal of the American College of Cardiology|October 21, 2015
Haptoglobin 2-2 Genotyping for Refining Standard Cardiovascular Risk Assessment: A Promising Proposition in Need of ValidationBenjamin D Horne, Jeffrey L Anderson
Pageof 40